New insights into p53 activation

被引:0
作者
Christopher L Brooks
Wei Gu
机构
[1] Stemline Therapeutics,and Department of Pathology
[2] Inc.,undefined
[3] Institute for Cancer Genetics,undefined
[4] College of Physicians & Surgeons,undefined
[5] Columbia University,undefined
来源
Cell Research | 2010年 / 20卷
关键词
Mdm2; antirepression; destabilization; ubiquitination; transcriptional activation and stability;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor p53 is a multifunctional, highly regulated, and promoter-specific transcriptional factor that is uniquely sensitive to DNA damage and cellular stress signaling. The mechanisms by which p53 directs a damaged cell down either a cell growth arrest or an apoptotic pathway remain poorly understood. Evidence suggests that the in vivo functions of p53 seem to balance the cell-fate choice with the type and severity of damage that occurs. The concept of antirepression, or inhibition of factors that normally keep p53 at bay, may help explain the physiological mechanisms for p53 activation. These factors also provide novel chemotherapeutic targets for the reactivation of p53 in tumors harboring a wild-type copy of the gene.
引用
收藏
页码:614 / 621
页数:7
相关论文
共 50 条
[21]   Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents [J].
Inoue, T ;
Geyer, RK ;
Yu, ZK ;
Maki, CG .
FEBS LETTERS, 2001, 490 (03) :196-201
[22]   DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma [J].
Wei, Shan ;
Xing, Jing ;
Chen, Jia ;
Chen, Liping ;
Lv, Jiapei ;
Chen, Xiaofei ;
Li, Tang ;
Yu, Tao ;
Wang, Huaying ;
Wang, Kai ;
Yu, Wanjun .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
[23]   Blue Light Damage and p53: Unravelling the Role of p53 in Oxidative-Stress-Induced Retinal Apoptosis [J].
Fietz, Agnes ;
Corsi, Francesca ;
Hurst, Jose ;
Schnichels, Sven .
ANTIOXIDANTS, 2023, 12 (12)
[24]   Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53 [J].
Xirodimas, DP ;
Stephen, CW ;
Lane, DP .
EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) :66-77
[25]   DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma [J].
Shan Wei ;
Jing Xing ;
Jia Chen ;
Liping Chen ;
Jiapei Lv ;
Xiaofei Chen ;
Tang Li ;
Tao Yu ;
Huaying Wang ;
Kai Wang ;
Wanjun Yu .
Journal of Experimental & Clinical Cancer Research, 43
[26]   Regulating the p53 system through ubiquitination [J].
Yang, YL ;
Li, CCH ;
Weissman, AM .
ONCOGENE, 2004, 23 (11) :2096-2106
[27]   Tickets for p53 journey among organelles [J].
Ferecatu, Ioana ;
Rincheval, Vincent ;
Mignotte, Bernard ;
Vayssiere, Jean-Luc .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 :4214-4228
[28]   The multiple levels of regulation by p53 ubiquitination [J].
Lee, J. T. ;
Gu, W. .
CELL DEATH AND DIFFERENTIATION, 2010, 17 (01) :86-92
[29]   The multiple levels of regulation by p53 ubiquitination [J].
J T Lee ;
W Gu .
Cell Death & Differentiation, 2010, 17 :86-92
[30]   C-Abl as a modulator of p53 [J].
Levav-Cohen, Y ;
Goldberg, Z ;
Zuckerman, V ;
Grossman, T ;
Haupt, S ;
Haupt, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) :737-749